Key Points: In today’s Recommendation for Industry, we discuss the encouraging trajectory of COVID based on TAG’s matrix and CDC’s mapping. Read more below. Women
Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it
The recent shortages of infant formula and the fallout from prior facility inspections of the manufacturer have most certainly energized Congress to take action that
FDA has been very clear that CBD is not approved for any uses in food or as a dietary supplement, and it has approved only
Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna
Key Points: In today’s Recommendation for Industry, we discuss the recent monkeypox outbreak. Read more below. In-utero COVID exposure tied to language, motor delays by
While the first quarter of 2022 saw fewer FDA food recalls than the previous quarter, the volume of those recalls increased by 274%, resulting in
Key Points: In today’s Recommendation for Industry, we discuss the westward movement of COVID and increase of BA.4 and BA. 5 in the U.S. Read
Bisphenol A (BPA) is associated with a myriad of negative connotations thanks to a perpetual campaign against the compound. For years, a relatively small group
